Atherosclerosis

Papers
(The H4-Index of Atherosclerosis is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
TNF-α/STEARATE INDUCED H3K9/18 HISTONE ACETYLATION AMPLIFIES IL-6 EXPRESSION IN ADIPOCYTES196
THE MOLECULAR BASIS OF DIFFERENT GENETIC LIPID DISORDERS IN LEBANON181
CARDIOVASCULAR MORBIDITYAMONG TUBERCULOSIS PATIENTS IN INDIA: A CROSS-SECTIONAL STUDY154
IMPACT OF CALEBIN-A ON KEY DIABETES-ASSOCIATED GENES148
ROLE OF PATIENT ADVOCATES IN SECURING APHERESIS ACCESS IN LEBANON139
Integrative prediction models of gestational diabetes mellitus: Insights from lipidomic profiling133
Inclisiran as monotherapy compared with placebo or ezetimibe in patients at low to borderline atherosclerotic cardiovascular disease risk: Results from the VICTORION-Mono randomized clinical trial126
Antibody functionalized lipoprotein complexes (LPC) including a repolarizing drug for the targeted therapy of atherosclerosis107
Quantitative data comparing LDL results produced by lipid ultracentrifugation with those calculated by the Sampson equation107
Browning of perivascular adipose tissue during early atherosclerosis progression: A contrast to clinical atherosclerosis104
Low residence time of exogeneous HDL is associated with preserved renal function in rats treated with HgCl2 and accumulation of HDL-protein in adipose tissue103
The effect of PCSK9 inhibitor treatment on plasma proteome in patients with and without familial hypercholesterolemia98
Modulating atherosclerotic plaque formation by targeting the plasminogen receptor Plg-RKT95
Sex-specific impact of the COVID-19 pandemic on metabolic syndrome prevalence94
Lp(a) levels in individuals with metabolic-dysfunction associated steatotic liver disease92
18FDG-pet imaging reveals glycolytic activity as a marker of atherosclerotic disease activity91
Levels of C5B-9, RGC-32 and SIRT1 in chronic and acute ischemic coronary artery disease84
Association of traditional cardiometabolic risk factors with atherosclerotic cardiovascular disease in familial hypercholesterolaemia individuals with severe elevation of LDL-cholesterol81
Rates of atherosclerotic cardiovascular events and their management in a longitudinal cohort of dermatomyositis patients with skin involvement79
Activated and regulatory T-helpers and blood monocytes in patients with HFPEF and type 2 diabetes mellitus78
Anti-endoglin monoclonal antibody inhibits the progression of liver sinusoidal endothelial inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis76
Noninvasive parameters of myocardial work and diastolic myocardial function in the assessment of heart failure with preserved ejection fraction in patients with postinfarction cardiosclerosis74
Clinical phenotypes of patients with stable coronary artery disease, with or without concomitant COVID-19, based on left ventricular function and cerebral blood flow74
Doxorubicin promotes atherosclerosis in an apolipoprotein e-deficient mouse model, potentially associated with serpina3n69
LATENT TB PREVALENCE AMONG DIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS66
ELEVEN YEARS FOLLOW-UP OF 1351 YOUNG FH-INDIVIDUALS IN NORWAY64
COMMUNITY ENGAGEMENT STRATEGY: ENHANCING VACCINE COVERAGE FOR CARDIOMETABOLIC DISEASE CONTROL62
Rabies vaccine induced microangiopathy60
Hepatic Cdkal1 deletion regulates HDL catabolism and promotes reverse cholesterol transport58
Genetic risk score for human serum lipidome and its association with angiographic coronary artery disease56
Effect of APOC3 inhibition with volanesorsen on hepatic steatosis in patients with severe hypertriglyceridemia54
IL-21R blockade reduces atherosclerosis development53
Antagonism of miR-148a attenuates the progression of atherosclerosis in APOBTGApobec-/-Ldlr+/- mice52
Methotrexate associated with a lipid core nanoparticle prevented the dilation and dissection of the aortic arch in mice with Marfan syndrome52
The role of systemic inflammation in reducing the elasticity of the main arteries in patients with chronic heart failure in combination with obesity51
Comparison of cardiovascular prognosis between triglyceride variability and exposure estimate in diabetic patients50
Effect of high- intensity extremely low frequency magnetic field on the intermediate stage atherosclerotic plaque remodeling: Monitored by histopathology and color doppler ultrasonography50
Silencing of PCSK9 by SIRNA-functionalized RHDL as tool to upregulate LDLR expression in hepatocytes50
Regulation of interleukin 1Β drives endothelial-to-mesenchymal transition of valve endothelial cells in patients with aortic valve sclerosis49
Size, fatty acid and protein characterization of different populations of extracellular vesicles obtained by sequential centrifugation. An useful tool to dissect their biological properties?49
Laser- mediated thermal angioplasty of occluded artery accompanied by disulphonated aluminum phthalocyanine - mediated photodynamic therapy combined with catheter- based ruthenium-106 brachytherapy48
TREM2 macrophages in adipose tissue and cardiovascular risk46
Targeted proteomics and the presence of carotid plaques in subjects at low cardiovascular disease risk45
Atherosclerosis in Brazil: An ecological study44
An upregulation of scube 2 expression in type 2 diabetes mellitus with dyslipidemia44
0.54855704307556